206 related articles for article (PubMed ID: 36386203)
1. Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer.
Liu Y; Du S; Yuan M; He X; Zhu C; Han K; Zhu Y; Yang Q; Tong R
Front Pharmacol; 2022; 13():949126. PubMed ID: 36386203
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma.
Sae-Fung A; Mutirangura A; Jitkaew S
Front Immunol; 2022; 13():1051273. PubMed ID: 36733386
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
[TBL] [Abstract][Full Text] [Related]
4. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
5. Disulfidptosis and ferroptosis related genes predict prognosis and personalize treatment for hepatocellular carcinoma.
Liu JF; Huang L; Zhou XP; Li CR; Liu MF; Liang YH; Yu QH; Wu JR
Transl Cancer Res; 2024 Feb; 13(2):496-514. PubMed ID: 38482398
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
Front Oncol; 2021; 11():730716. PubMed ID: 34557413
[TBL] [Abstract][Full Text] [Related]
7. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
Wang X; Meng Y; Liu C; Yang H; Zhou S
J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
[TBL] [Abstract][Full Text] [Related]
8. Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Xu Y; Du Y; Zheng Q; Zhou T; Ye B; Wu Y; Xu Q; Meng X
Front Immunol; 2022; 13():895110. PubMed ID: 35603151
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
10. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
Front Oncol; 2021; 11():686044. PubMed ID: 34422642
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
12. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
Yang S; Ji J; Wang M; Nie J; Wang S
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830675
[TBL] [Abstract][Full Text] [Related]
13. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma.
Guo W; Wang X; Wang Y; Zhu S; Zhu R; Zhu L
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555319
[TBL] [Abstract][Full Text] [Related]
15. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
Liu G; Ma JY; Hu G; Jin H
PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
19. The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma.
Chen X; Zhu Z; Li X; Yao X; Luo L
Front Oncol; 2021; 11():778557. PubMed ID: 34790582
[TBL] [Abstract][Full Text] [Related]
20. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
